TCM
ANTX icon

TCG Crossover Management’s AN2 Therapeutics ANTX Stock Holding History

TCG Crossover Management’s Portfolio ANTX Stock Details ANTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,555,118
Closed -$1.66M – 39
2024
Q3 		$1.66M Hold
1,555,118
– – 0.14% 34
2024
Q2 		$3.34M Hold
1,555,118
– – 0.35% 29
2024
Q1 		$5.05M Sell
1,555,118
-1,123,091
-42% -$12.2M 0.4% 29
2023
Q4 		$54.9M Hold
2,678,209
– – 6.09% 4
2023
Q3 		$43.1M Buy
2,678,209
+1,388,889
+108% +$15.7M 6.34% 4
2023
Q2 		$11M Buy
+1,289,320
New +$9.27M 1.8% 16

Other funds holding ANTX

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $122M AUM 67.29% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of Nova Scotia
Bank of Nova Scotia Toronto, Ontario, Canada $57.2B AUM 35.3% 1-Year Est. Return